VSTM as of Nov 1 · 14:00 ET
VSTMNasdaqPharmaceutical Preparations
Verastem, Inc. · Brief
Next report
2 days
Nov 3 · before openest.Q3 FY26
Expected move
Inputs0 of 6≥ implied
- avg implied
- ±39.3%
- avg realized
- ±10.8%
Aug 8 '22±46.4%▲+7.56%×0.16
Feb 2 '23±48.6%▲+8.65%×0.18
Jan 13 '25±10.2%▼−6.81%×0.67
Q3 FY25±46.6%▼−20.10%×0.43
Q1 FY26±51.5%▲+7.78%×0.15
Q2 FY26±32.6%▲+14.04%×0.43
quarterimplied−55%0+55%realized×
Q2 FY26±32.6%▲+14.04%×0.43
Q1 FY26±51.5%▲+7.78%×0.15
Q3 FY25±46.6%▼−20.10%×0.43
Jan '25±10.2%▼−6.81%×0.67
Feb '23±48.6%▲+8.65%×0.18
Aug '22±46.4%▲+7.56%×0.16
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Nov 3 report · est.Bull2 of 3
+30.31%ten largest reporting managers increasing their reported shares over the latest quarter13F · Jun 30 '26
Bear2 of 3
3 of 24several of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case
Linked exposure
VSTM report sessionNo linked exposure.
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.